Cleared Traditional

CATHETER, SILICONE FOLEY (BARDEX) (K760093) - FDA 510(k) Clearance

Class II Gastroenterology & Urology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K760093 · C.R. Bard, Inc. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1976
Decision
63d
Days
Class 2
Risk

K760093 is an FDA 510(k) clearance for the CATHETER, SILICONE FOLEY (BARDEX). Classified as Catheter, Urethral (product code GBM), Class II - Special Controls.

Submitted by C.R. Bard, Inc. (Mchenry, US). The FDA issued a Cleared decision on August 23, 1976 after a review of 63 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5130 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all C.R. Bard, Inc. devices

Submission Details

510(k) Number K760093 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 21, 1976
Decision Date August 23, 1976
Days to Decision 63 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 130d · This submission: 63d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GBM Catheter, Urethral
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - GBM Catheter, Urethral

All 70
Devices cleared under the same product code (GBM) and FDA review panel - the closest regulatory comparables to K760093.
Wellead® Hydrophilic Intermittent Catheter Ready to Use
K241734 · Well Lead Medical Co., Ltd. · Mar 2025
GentleCath Air for Men Hydrophilic Intermittent Urinary Catheter
K213283 · Convatec Limited · Jun 2022
Intermittent Catheter (Not Finalized)
K211436 · Hollister Incorporated · Jan 2022
SpeediCath Compact Set
K200820 · Coloplast · Nov 2020
SpeediCath Compact Set
K192904 · Coloplast · Nov 2020
SpeediCath Soft
K200142 · Coloplast · Jul 2020